Higher concentrations aren't necessarily better and can increase the risk of irritation
Food and Drug Administrations Pharmacy Compounding Advisory Committee (PCAC) has completed its review of seven peptide substances nominated for inclusion on the Section 503A Bulks List, recommending that BPC-157, KPV, TB-500, and MOTS-c be included among the bulk drug substances that may be used by state-licensed traditional compounding pharmacies under Section 503A of the Federal Food, Drug, and Cosmetic Act
However, clinicians should remain cautious and consider individual health profiles when recommending prolonged therapy
[13] Overall, for the majority of users the side effects are mild and temporary, but anyone experiencing persistent or severe symptoms should seek medical attention
With GHK-Cu, the future of beauty is not just skin-deep